• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NK(2)速激肽受体对兔远端结肠推进运动的作用

Contribution of NK(2) tachykinin receptors to propulsion in the rabbit distal colon.

作者信息

Onori L, Aggio A, Taddei G, Tonini M

机构信息

Department of Internal Medicine and Public Health, University of L'Aquila, 67100 L'Aquila, Italy.

出版信息

Am J Physiol Gastrointest Liver Physiol. 2000 Jan;278(1):G137-47. doi: 10.1152/ajpgi.2000.278.1.G137.

DOI:10.1152/ajpgi.2000.278.1.G137
PMID:10644572
Abstract

The role of the tachykinin neurokinin (NK)(2) receptors on rabbit distal colon propulsion was investigated by using two selective NK(2)-receptor antagonists, MEN-10627 and SR-48968. Experiments on colonic circular muscle strips showed that contractile responses to [beta-Ala(8)]NKA-(4-10) (1 nM-1 microM), a selective NK(2)-receptor agonist, were competitively antagonized by MEN-10627 (1-100 nM), whereas SR-48968 (0.1-10 nM) caused an insurmountable antagonism, thus confirming the difference in the mode of action of the two compounds. Colonic propulsion was elicited by distending a mobile rubber balloon with 0.3 ml (submaximal stimulus) or 1.0 ml (maximal stimulus) of water. The velocity of anal displacement of the balloon (mm/s) was considered the main propulsion parameter. At low concentrations (1.0-100 nM and 0.1-10 nM, respectively), MEN-10627 and SR-48968 facilitated the velocity of propulsion, whereas at high concentrations (100 nM and 1 microM, respectively) they decelerated propulsion. The excitatory and inhibitory effects of both antagonists were observed only with submaximal stimulus. We focused on the hypothesis that the facilitatory effect on propulsion may result from blockade of neuronal NK(2) receptors and the inhibitory effect from suppression of the excitatory transmission mediated by NK(2) receptors on smooth muscle cells. In the presence of N(G)-nitro-L-arginine (300 microM), a nitric oxide synthase inhibitor, MEN-10627, at a concentration (10 nM) that was found to accelerate propulsion in control experiments inhibited the velocity of propulsion. In the presence of threshold (1-10 nM) or full (1 microM) concentration of atropine, which inhibited to a great extent the velocity of propulsion, the inhibitory effect of MEN-10627 (1 microM) was markedly increased. In conclusion, in the rabbit distal colon NK(2) receptors may decelerate propulsion by activating a nitric oxide-dependent neuronal mechanism and may accelerate it by a postjunctional synergistic interaction with cholinergic muscarinic receptors.

摘要

通过使用两种选择性神经激肽(NK)(2)受体拮抗剂MEN-10627和SR-48968,研究了速激肽神经激肽(NK)(2)受体对兔远端结肠推进作用的影响。对结肠环形肌条的实验表明,选择性NK(2)受体激动剂[β-丙氨酸(8)]NKA-(4-10)(1 nM - 1 μM)引起的收缩反应被MEN-10627(1 - 100 nM)竞争性拮抗,而SR-48968(0.1 - 10 nM)引起不可克服的拮抗作用,从而证实了这两种化合物作用方式的差异。通过向可移动的橡胶球囊中注入0.3 ml(次最大刺激)或1.0 ml(最大刺激)水来引发结肠推进。球囊肛门位移速度(mm/s)被视为主要推进参数。在低浓度(分别为1.0 - 100 nM和0.1 - 10 nM)时,MEN-10627和SR-48968促进推进速度,而在高浓度(分别为100 nM和1 μM)时它们使推进减速。两种拮抗剂的兴奋和抑制作用仅在次最大刺激时观察到。我们关注这样一种假设,即对推进的促进作用可能源于神经元NK(2)受体的阻断,而抑制作用源于NK(2)受体介导的平滑肌细胞兴奋传递的抑制。在一氧化氮合酶抑制剂N(G)-硝基-L-精氨酸(300 μM)存在的情况下,在对照实验中发现能加速推进的浓度(10 nM)的MEN-10627抑制了推进速度。在阈值(1 - 10 nM)或完全(1 μM)浓度的阿托品存在的情况下,阿托品在很大程度上抑制了推进速度,MEN-1(1 μM)的抑制作用明显增强。总之,在兔远端结肠中,NK(2)受体可能通过激活一氧化氮依赖性神经元机制使推进减速,并可能通过与胆碱能毒蕈碱受体的接头后协同相互作用使其加速。

相似文献

1
Contribution of NK(2) tachykinin receptors to propulsion in the rabbit distal colon.NK(2)速激肽受体对兔远端结肠推进运动的作用
Am J Physiol Gastrointest Liver Physiol. 2000 Jan;278(1):G137-47. doi: 10.1152/ajpgi.2000.278.1.G137.
2
The role of tachykinin NK1 and NK2 receptors in atropine-resistant colonic propulsion in anaesthetized guinea-pigs.速激肽NK1和NK2受体在麻醉豚鼠对阿托品抵抗的结肠推进中的作用
Br J Pharmacol. 1998 May;124(1):27-34. doi: 10.1038/sj.bjp.0701789.
3
Contribution of NK3 tachykinin receptors to propulsion in the rabbit isolated distal colon.NK3速激肽受体对兔离体远端结肠推进运动的作用
Neurogastroenterol Motil. 2001 Jun;13(3):211-9. doi: 10.1046/j.1365-2982.2001.00261.x.
4
Tachykinin NK-1 and NK-2 receptors in the circular muscle of the guinea-pig proximal colon.豚鼠近端结肠环行肌中的速激肽NK-1和NK-2受体
Regul Pept. 1993 Jul 2;46(1-2):386-8. doi: 10.1016/0167-0115(93)90095-p.
5
A selective NK-2 antagonist blocks the increase of canine colonic tone and ileal contractions induced by the NK-2 selective receptor agonist, [beta Ala8] neurokinin A-(4-10).一种选择性NK-2拮抗剂可阻断由NK-2选择性受体激动剂[β丙氨酸8]神经激肽A-(4-10)诱导的犬结肠张力增加和回肠收缩。
Aliment Pharmacol Ther. 1994 Oct;8(5):527-33. doi: 10.1111/j.1365-2036.1994.tb00326.x.
6
Tachykinin NK(2) receptors and enhancement of cholinergic transmission in the inflamed rat colon: an in vivo motility study.速激肽NK(2)受体与炎症大鼠结肠胆碱能传递增强:一项体内运动性研究
Br J Pharmacol. 2001 Aug;133(7):1107-13. doi: 10.1038/sj.bjp.0704164.
7
In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.速激肽NK2受体对人结肠肌条运动反应调节作用的体外特性研究
Br J Pharmacol. 1998 Jul;124(6):1321-7. doi: 10.1038/sj.bjp.0701960.
8
Bidirectional regulation of human colonic smooth muscle contractility by tachykinin NK(2) receptors.速激肽 NK(2)受体对人结肠平滑肌收缩性的双向调节。
J Pharmacol Sci. 2011;117(2):106-15. doi: 10.1254/jphs.11118fp. Epub 2011 Sep 23.
9
Role of tachykinin NK1 and NK2 receptors on colonic motility in anesthetized rats: effect of agonists.速激肽NK1和NK2受体在麻醉大鼠结肠运动中的作用:激动剂的影响
Can J Physiol Pharmacol. 1997 Jun;75(6):582-6.
10
Effect of nepadutant at tachykinin NK(2) receptors in human intestine and urinary bladder.
Eur J Pharmacol. 2000 Jun 23;398(3):389-97. doi: 10.1016/s0014-2999(00)00346-0.

引用本文的文献

1
Contractile effect of tachykinins on rabbit small intestine.速激肽对兔小肠的收缩作用。
Acta Pharmacol Sin. 2011 Apr;32(4):487-94. doi: 10.1038/aps.2010.227. Epub 2011 Mar 28.
2
Current and novel therapeutic options for irritable bowel syndrome management.目前用于肠易激综合征治疗的新型治疗选择。
Dig Liver Dis. 2009 Dec;41(12):854-62. doi: 10.1016/j.dld.2009.07.009. Epub 2009 Aug 8.
3
Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.肠易激综合征治疗渠道面临的挑战:终点指标与监管障碍
Gastroenterology. 2008 Dec;135(6):1877-91. doi: 10.1053/j.gastro.2008.09.005. Epub 2008 Oct 9.
4
Irritable bowel syndrome: recent and novel therapeutic approaches.肠易激综合征:近期及新颖的治疗方法
Drugs. 2006;66(8):1073-88. doi: 10.2165/00003495-200666080-00004.
5
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.用于治疗肠易激综合征的速激肽NK2受体拮抗剂。
Br J Pharmacol. 2004 Apr;141(8):1249-63. doi: 10.1038/sj.bjp.0705751. Epub 2004 Mar 22.
6
Tachykinin NK(2) receptors and enhancement of cholinergic transmission in the inflamed rat colon: an in vivo motility study.速激肽NK(2)受体与炎症大鼠结肠胆碱能传递增强:一项体内运动性研究
Br J Pharmacol. 2001 Aug;133(7):1107-13. doi: 10.1038/sj.bjp.0704164.
7
Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.肠易激综合征:靶向5-羟色胺受体亚型的新型药物
Drugs. 2001;61(3):317-32. doi: 10.2165/00003495-200161030-00001.